Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Change in Inventory: 2023-2024

Historic Change in Inventory for Tg Therapeutics (TGTX) over the last 2 years, with Dec 2024 value amounting to $66.9 million.

  • Tg Therapeutics' Change in Inventory fell 442.32% to -$8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.8 million, marking a year-over-year increase of 23.77%. This contributed to the annual value of $66.9 million for FY2024, which is 80.98% up from last year.
  • As of FY2024, Tg Therapeutics' Change in Inventory stood at $66.9 million, which was up 80.98% from $36.9 million recorded in FY2023.
  • Tg Therapeutics' Change in Inventory's 5-year high stood at $66.9 million during FY2024, with a 5-year trough of $36.9 million in FY2023.
  • For the 2-year period, Tg Therapeutics' Change in Inventory averaged around $51.9 million, with its median value being $51.9 million (2023).
  • Data for Tg Therapeutics' Change in Inventory shows a peak YoY soared of 80.98% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Tg Therapeutics' Change in Inventory stood at $36.9 million in 2023, then spiked by 80.98% to $66.9 million in 2024.